Management of the chronic leukemias: Special considerations in the elderly patient. Part I. Chronic lymphocytic leukemias

Hematology

Volumn 6, Issue 5, 2001, Pages 291-314

  Spiers, A S D ^a  

^a H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

Author keywords

Chronic leukemias; Chronic lymphocytic leukemia (CLL); Geriatric patients; Hematologic neoplasms; Therapy

Indexed keywords

ALKYLATING AGENT; ALLOPURINOL; ANDROGEN; ANTHRACYCLINE ANTIBIOTIC AGENT; CARMUSTINE; CHLORAMBUCIL; CLADRIBINE; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYTARABINE; DEXAMETHASONE; DOXORUBICIN; ESTROGEN; FLUCONAZOLE; FLUDARABINE; IMMUNOGLOBULIN; IMMUNOTOXIN; MELPHALAN; MONOCLONAL ANTIBODY; PENTOSTATIN; PREDNISOLONE; PREDNISONE; URIC ACID; VINCRISTINE;

ACNE; ADULT; AGED; ALLOGENIC BONE MARROW TRANSPLANTATION; ALOPECIA; ANEMIA; ARTICLE; CANCER CLASSIFICATION; CANCER RADIOTHERAPY; CANCER STAGING; CANDIDA; CANDIDIASIS; CHRONIC LYMPHATIC LEUKEMIA; CLINICAL FEATURE; CONTROLLED STUDY; CYSTITIS; DISEASE COURSE; DRUG EFFICACY; DRUG MECHANISM; DRUG SAFETY; ELDERLY CARE; ERYTHROCYTE TRANSFUSION; GASTROINTESTINAL DISEASE; HEART DISEASE; HEMATOLOGIC DISEASE; HIRSUTISM; HUMAN; HYPERTENSION; IMMUNE DEFICIENCY; INFECTION; LIVER DISEASE; METABOLIC DISORDER; OSTEOPOROSIS; PRIORITY JOURNAL; PROGNOSIS; PROSTATE HYPERTROPHY; PSYCHOSIS; RASH; SPLENECTOMY; STEM CELL TRANSPLANTATION; TREATMENT INDICATION; TREATMENT OUTCOME;

EID: 0035663356     PISSN: 10245332     EISSN: None     Source Type: Journal    
DOI: 10.1080/10245332.2001.11746584     Document Type: Article

References (109)

1. "Therapeutic management of hematological malignancies in elderly patients. Biological and clinical considerations"
2. "T-cell chronic lymphocytic leukaemia: Anomalous cell markers, variable morphology, and marked responsiveness to pentostatin (2′-deoxycoformycin)"
3. "Descriptive epidemiology of the leukemias"
4. "Open heart surgery in patients with chronic lymphocytic leukemia"
5. "Chronic lymphocytic leukemia with hyperleukocytosis. The hyperviscosity syndrome"
6. "Meningeal involvement in early stage chronic lymphocytic leukemia"
7. "Guidelines for clinical protocols for chronic lymphocytic leukemia (CLL). Recommendations of the NCI-Sponsored Working Group"
8. "Chromosome abnormalities in B-cell chronic lymphocytic leukemia"
9. "In B-cell chronic lymphocytic leukaemia chromosome 17 abnormalities and not trisomy 12 are the single most important cytogenetic abnormalities for the prognosis: A cytogenetic and immunophenotypic study of 480 diagnosed patients"
10. "Prolymphocytoid" transformation of chronic lymphocytic leukemia"
11. "Prolymphocytic transformation in chronic lymphocytic leukemia presenting as bilateral periorbital swelling"
12. "Prolymphocytic transformation of B-chronic lymphocytic leukemia presenting as malignant ascites and pleural effusion"
13. "Generalized reticular cell sarcoma of lymph nodes associated with lymphatic leukemia"
14. "Chronic lymphocytic leukemia"
15. "Associated chronic lymphocytic leukemia and multiple myeloma: Origin from a single clone"
16. "Acute blast crisis in a patient with chronic lymphocytic leukemia: Immunoperoxidase study"
17. "Splenic leukemia with carcinoma"
18. "Leukemia and cancer in the same patient"
19. "Second neoplasms with chronic lymphocytic leukemia"
20. "A new prognostic classification of chronic lymphocytic leukemia derived from a multivariate survival analysis"
21. "Survival in chronic lymphocytic leukemia"
22. "Serum immunoglobulins in B-chronic lymphocytic leukemia. Natural history and prognostic significance"
23. "Chronic lymphocytic leukemia"
24. "Chronic lymphocytic leukemia clinical studies based on 189 cases followed for a long time"
25. "The pathogenesis of chronic lymphocytic leukemia"
26. "Lymphocyte doubling time in chronic lymphocytic leukemia: An update of its prognostic significance"
27. "Bone marrow infiltration patterns and their prognostic significance in chronic lymphocytic leukemia: Correlations with clinical, immunologic, phenotypic, and cytogenetic data"
28. "Prognostic significance of immunoglobulin phenotype in B cell chronic lymphocytic leukemia"
29. "Behaviour of serum beta 2-microglobulin and acute phase reactant proteins in chronic lymphocytic leukaemia"
30. "Beta 2-microglobulin in chronic lymphocytic leukaemia"
31. "Prognostic value of B-cell mitogen-induced and spontaneous thymidine uptake in vitro in chronic B-lymphocytic leukaemia cells"
32. "Serum deoxythymidine kinase gives prognostic information in chronic lymphocytic leukemia"
33. "Correlation of total body potassium and leukemic cell mass in patients with chronic lymphocytic leukemia"
34. "Factors influencing the duration of survival of patients with chronic lymphocytic leukemia"
35. "Chronic lymphocytic leukemia - An accumulative disease of immunologically incompetent lymphocytes"
36. "Clinical staging of chronic lymphocytic leukemia"
37. "A new prognostic classification of chronic lymphocytic leukemia derived from a multivariate survival analysis"
38. "Proposal for a revised prognostic staging system"
39. "Chronic lymphocytic leukemia"
40. "Chronic lymphocytic leukemia"
41. "An outline of clinical management of chronic lymphocytic leukemia"
42. "Chemotherapy of chronic lymphocytic leukemia"
43. "Radiation in chronic lymphocytic leukemia"
44. "High dose methyl prednisolone in refractory chronic lymphocytic leukemia"
45. "Androgenic hormone therapy in lymphatic leukemia"
46. "Oxymethalone in myelofibrosis and chronic lymphocytic leukemia"
47. "The treatment of bone marrow failure with massive androgen therapy"
48. "Lymphopenic response of patients presenting with chronic lymphocytic leukemia associated with carcinoma of the prostate to diethylstilbestrol: Correlation of response to the in vitro synthesis of RNA by patient relationship to transcortin"
49. Responses to diethylstilbestrol in a patient with refractory chronic lymphatic leukemia associated with non-Hodgkin's lymphoma (Richter's syndrome)
50. "Clinical trials of p(di-2-chloroethylamino)-phenylbutyric acid (CB1348) in malignant lymphoma"
51. "Chlorambucil vs. combined chlorambucil-corticosteroid therapy in chronic lymphocytic leukemia"
52. "Treatment of chronic lymphocytic leukemia"
53. "Biweekly chlorambucil treatment of chronic lymphocytic leukemia"
54. "Comparison of daily versus intermittent chlorambucil and prednisone therapy in the treatment of patients with chronic lymphocytic leukemia"
55. "Chlorambucil in indolent chronic lymphocytic leukemia"
56. "Chlorambucil-induced pulmonary disease: A case report and review of the literature"
57. "Untreated chronic lymphocytic leukemia concurrent with or followed by acute myelogenous leukemia or myelodysplastic syndrome"
58. "Haemorrhagic cystitis after low-dose cyclophosphamide"
59. "Effectiveness of "CHOP" Regimen in advanced untreated chronic lymphocytic leukaemia"
60. "Combination chemotherapy of advanced chronic lymphocytic leukemia: The M-2 protocol (vincristine, BCNU, cyclophosphamide, melphalan and prednisone)"
61. "Multiple agent chemotherapy (POACH) in previously treated and untreated patients with chronic lymphocytic leukemia"
62. "The value of splenectomy in chronic lymphocytic leukemia"
63. "Splenectomy in advanced chronic lymphocytic leukemia"
64. "Splenectomy for thrombocytopenia in chronic lymphocytic leukemia"
65. "Splenectomy during chronic lymphocytic leukemia"
66. "Splenectomy for end-stage chronic lymphocytic leukemia"
67. "Chronic lymphocytic leukemia: Recommendations for diagnosis, staging and response criteria"
68. "Specificity of adenosine deaminase toward adenosine and 2′-deoxyadenosine analogues"
69. "Pharmacokinetics of 2-F-ara-A (9-beta-D-arabinofuranosyl-2-fluoroadenine) in cancer patients during the Phase I clinical investigation of fludarabine phosphate"
70. "Metabolism and action of fludarabine phosphate"
71. "Phase I clinical trials with fludarabine phosphate"
72. "Central nervous system toxicity of fludarabine phosphate"
73. "Fludarabine monophosphate: A potentially useful agent in chronic lymphocytic leukemia"
74. "Fludarabine: A new agent with major activity against chronic lymphocytic leukemia"
75. "Fludarabine: A new agent with marked cytoreductive activity in untreated chronic lymphocytic leukemia"
76. "Long-term follow-up of patients with chronic lymphocytic leukemia treated with fludarabine as a single agent"
77. "Fludarabine (FLU)-Prednisone (PRED): A safe, effective combination in refractory chronic lymphocytic leukemia"
78. "Long-term follow-up of patients with chronic lymphocytic leukemia (CLL) receiving fludarabine regimens as initial therapy"
79. "Multicentre prospective randomised trial of fludarabine versus cyclophosphamide, doxorubicin, and prednisone (CAP) for treatment of advanced-stage chronic lymphocytic leukaemia"
80. "Comparison of fludarabine (FDB), CAP and CHOP in previously untreated stage B chronic lymphocytic leukemia (CLL0). First interim results of a randomized clinical trial in 247 patients"
81. "A randomized comparison of fludarabine and chlorambucil for patients with previously untreated chronic lymphocytic leukemia. A CALGB, SWOG, CTG/NCI-C and ECOG intergroup study"
82. "Combined therapy with fludarabine and cyclophosphamide in relapsed/resistant patients with B-cell chronic lymphocytic leukaemia and non-Hodgkin's lymphomas"
83. "Fludarabine and epirubicin in the treatment of chronic lymphocytic leykaemia: A German multicenter phase II study"
84. "National Cancer Institute-Sponsored Working Group guidelines for chronic lymphocytic leukemia: Revised guidelines for diagnosis and treatment"
85. "2-chlorodeoxyadenosine (cladribine) in the treatment of elderly patients with B-cell chronic lymphocytic leukemia"
86. "Effectiveness of pentostatin (2′-deoxycoformycin) in refractory lymphoid neoplasms"
87. "Phase I/II evaluation of pentostatin (2′-deoxycoformycin) in a five day schedule for the treatment of relapsed/refractory B-cell chronic lymphocytic leukaemia"
88. "Autoimmune hemolytic anemia in chronic lymphocytic leukemia patients treated with fludarabine"
89. "Fludarabine-related autoimmune haemolytic anaemia in patients with chronic lymphocytic leukaemia"
90. "Severe autoimmune hemolytic anemia in eight patients treated with fludarabine"
91. "Fludarabine-related hemolytic anemia in chronic lymphocytic leukemia and lymphoproliferative disorders"
92. "Relevance of autocytotoxic and autoregulatory lymphocytes in the maintenance of tolerance"
93. "Tumor lysis syndrome complicating treatment of chronic lymphocytic leukemia with fludarabine phosphate"
94. "Tumor lysis syndrome: An uncommon complication of fludarabine therapy of chronic lymphocytic leukemia"
95. "Secondary neoplasms in two patients treated with purine analogues"
96. "Myelodysplasia occurring after fludarabine treatment for chronic lymphocytic leukaemia"
97. "Immunological abnormalities in myelodysplastic syndromes II. Coexistent lymphoid or plasma cell neoplasms: A report of 20 cases unrelated to chemotherapy"
98. "Drug resistance in chronic lymphocytic leukemia"
99. "Resistance of human leukemic and normal lymphocytes to DNA cleavage by drugs correlates with low levels of DNA topoisomerase"
100. "Is the mdr 1 gene relevant in chronic lymphocytic leukemia?"
101. "Multi-drug resistance in chronic lymphocytic leukemia"
102. "Prognosis for fludarabine therapy of chronic lymphocytic leukaemia based on ex vivo drug response by DiSC assay"
103. "Intravenous immunoglobulin for the prevention of infection in chronic lymphocytic leukemia. A randomized, controlled clinical trial"
104. "Infection in chronic lymphocytic leukemia: A reappraisal"
105. "Innovative treatment strategies for chronic lymphocytic leukemia: Monoclonal antibodies, immunoconjugates, and bone marrow transplantation"
106. "Autologous hematopoietic stem cell transplantation as salvage treatment for advanced B cell chronic lymphocytic leukemia"
107. "Early stem cell transplantation for chronic lymphocytic leukemia: A chance for cure?"